NCT01438658View on ClinicalTrials.gov

Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2040

Study Completion Date

December 31, 2040

Conditions

Uveal Melanoma

Trial Locations (1)

91120

RECRUITING

Specialized Ocular Oncology Service, Hadassah-Hebrew-University Medical Center, Jerusalem

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER

NCT01438658 - Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma | Biotech Hunter | Biotech Hunter